Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dynal Biotech is a pioneering life sciences company renowned for developing the first uniform superparamagnetic beads, known as Dynabeads. These beads revolutionized the separation and manipulation of biological targets, including cells, proteins, and nucleic acids, by providing a highly consistent and reproducible solid phase. The company's technology is a cornerstone of modern immunology and molecular biology, particularly in the manufacturing of advanced cell therapies like CAR-T. Dynabeads are used globally in both research and clinical diagnostic settings for applications ranging from automated blood typing to pathogen detection. Founded in Norway in 1986, Dynal was acquired by Invitrogen in 2005 and is now a key brand within the Thermo Fisher Scientific portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dynal.